A clinical trial to study the effects of two drugs, nagaradi eye drops and vachaharidradi application in patients with allergic conjuctivitis
Phase 1
- Conditions
- Health Condition 1: H108- Other conjunctivitis
- Registration Number
- CTRI/2020/04/024696
- Lead Sponsor
- Dr Meenu P R
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients above 5 years
Patients presenting with clinical features of Kaphaja Abhishyanda(Simple allergic conjunctivitis) will be selected
Exclusion Criteria
Patients having other types of Conjuctivitis, Marginal corneal ulcer, Dacryocystitis and other ocular manifestations
Patients suffering with systemic disorders
Patients having genetic predisposition to allergy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Watering of eye <br/ ><br>2.Itching <br/ ><br>3.Burning sensation <br/ ><br>4.Congestion of bulbar and palpebral conjuctiva <br/ ><br>5.Chemosis <br/ ><br>6.Papillary reaction <br/ ><br>7.Foreign body sensation <br/ ><br>Timepoint: 21 days
- Secondary Outcome Measures
Name Time Method ot applicableTimepoint: Not applicable